Categories: Invest

Amgen stock price forecast for Q3 2021 after declaring dividend ahead of Q2 results

Amgen Inc. (NASDAQ:AMGN) shares traded flat on Friday despite declaring a $1.76 Q3 dividend per share. The company will pay the dividend on 8th September to shareholders of record on 17th August. In addition, Amgen reports its fiscal Q2 results on 3rd August, and after missing analyst expectations on Q1 earnings, the stock price could be exciting going into August.

Based on the company’s closing price of $241.54 on Friday, it is now paying dividends at a forward yield of 2.91%. Analysts expect Amgen’s annual dividend per share to grow to $7.50 next year, up from $6.93 this year, before hitting $8.25 in the fiscal year 2023.

Should you invest in Amgen shares in Q3 2021?


Are you looking for fast-news, hot-tips and market analysis?

Sign-up for the Invezz newsletter, today.

Amgen shares trade at an attractive P/E ratio of 20.08. In addition, its forward P/E ratio of just 13.46 will be compelling to value investors. However, analysts expect AMGN’s earnings to decline by 4.40% this year before increasing by 9.82% next year. Therefore, there could be some bottlenecks in the short term.

Nonetheless, investors can look forward to the generous compensation the company offers through dividend payments. Based on next year’s forecast annual dividend per share, Amgen could trade a yield of 3.09%, making it compelling to dividend investors.

Source – TradingView

Technical overview: why Amgen shares could bounce back ahead of Q2 results

Amgen stock is down 2.49% this week and nearly 15% off its yearly highs of $276.69, reached at the end of January. However, this week’s decline has pushed AMGN shares to the trendline support, creating an opportunity for a rebound.

Furthermore, given the dividend announcement and the upcoming earnings report, investors will be assessing ways to invest in the Thousand Oaks, CA-based biopharmaceuticals company.

Investors can target rebound profits at approximately $246.19 or higher at $250.11, while $237.16 and $233.62 are crucial support levels.

Bottom line: the case for buying AMGN stock price rebound

In summary, although Amgen earnings could decline this year before rising next year, the stock looks attractively valued. Furthermore, the recent pullback seems to be finding support off the trendline, creating an opportunity for a rebound. Therefore, the 3rd August earnings report could be the catalyst.

Where to buy right now

To invest simply and easily, users need a low-fee broker with a track record of reliability. The following brokers are highly rated, recognised worldwide, and safe to use:

  1. Etoro, trusted by over 13m users worldwide. Register here >
  2. Capital.com, simple, easy to use and regulated. Register here >
admin

Share
Published by
admin

Recent Posts

Is there a way for the crypto sector to avoid Bitcoin’s halving-related bear markets?

There is good reason to be afraid. Previous down markets have seen declines in excess…

2 years ago

UPS and FedEx are good dividend stocks, but which should you take?

United Parcel Service, Inc. (NYSE:UPS) and FedEx Corporation (NYSE:FDX) are two robust logistics companies. Both…

2 years ago

Bitfarms sold 3K Bitcoin as part of strategy to improve liquidity and pay debts

Canadian crypto mining firm Bitfarms sold roughly $62 million worth of Bitcoin (BTC) in June,…

2 years ago

This biotech stock is up 100% on Tuesday: here’s the catalyst

Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling…

2 years ago

Japanese film studio announces the production of a series based on crypto

Noma, a Japanese film studio, has announced that it is producing three feature films that…

2 years ago

Bitcoin price taps 5-day highs as Shiba Inu leads altcoin gains

Bitcoin (BTC) saw continued strength on June 21 as Wall Street trading opened with a…

2 years ago